CN104189879A - Formula for treating immunocom promise - Google Patents
Formula for treating immunocom promise Download PDFInfo
- Publication number
- CN104189879A CN104189879A CN201410509478.7A CN201410509478A CN104189879A CN 104189879 A CN104189879 A CN 104189879A CN 201410509478 A CN201410509478 A CN 201410509478A CN 104189879 A CN104189879 A CN 104189879A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- formula
- zingiberis recens
- rhizoma zingiberis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of traditional Chinese medicine, in particular to a formula for treating immunocom promise. The formula is characterized by comprising the following materials in parts by weight: 22-26 parts of Chinese thorowax, 8-12 parts of baical skullcap root, 10-14 parts of ginger processed pinellia, 4-8 parts of mirabilite, 8-12 parts of red ginseng, 10-14 parts of jujube, 8-12 parts of cassia twig, 8-12 parts of ginger, 10-14 parts of white paeony root and 4-8 parts of honey-fried licorice root. The formula clears and relieves suffocating and hot and nurses qi activity through the Chinese thorowax and the mirabilite, regulates ying and wei and dissipates heat through the cassia twig, is good in curative effect, and has no negative side effect.
Description
Technical field
The present invention relates to the field of Chinese medicines, especially a kind of formula for the treatment of immunologic hypofunction.
Background technology
Immunity is the defense mechanism of human body self, is human body identification and any foreign body of eliminating external intrusion, processes the ability of self cell and identification and processing vivo mutations cell and the virus infected cell of old and feeble, damage, dead, degeneration.
Modern immunology thinks, immunity is human body identification and the physiological reaction of getting rid of " dissident "; A variety of causes makes immune system normally not bring into play protective effect, in the case, very easily causes the infection such as antibacterial, virus, fungus, thus hypoimmunity the most directly to show be exactly liable to illness; And often ill, increased the weight of the consumption of body, thus generally have a delicate constitution, the performance such as malnutrition, listlessness, fatigue and weak, appetite depression, sleep disorder, sick, have an injection and take medicine the normal potluck that just gets married; Each sickly all will could recover for a long time, and usually outbreak repeatedly, if things go on like this can cause health and intelligent development bad, also easily brings out major disease; Underlying causes is that hypoimmunity or immunity are unsound, when immune function of human body imbalance, or when immune system is unsound, will cause that flu is shown effect repeatedly, tonsillitis is shown effect repeatedly, asthma is shown effect repeatedly, bronchitis shows effect repeatedly, pneumonia is shown effect repeatedly, suffer from diarrhoea and repeatedly send out etc.
Summary of the invention
A formula for the treatment of immunologic hypofunction, is characterized in that: described quality proportioning is selected as 22 ~ 26 parts of Radix Bupleuri, 8 ~ 12 parts of Radix Scutellariaes, 10 ~ 14 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 4 ~ 8 parts, Natrii Sulfas, 8 ~ 12 parts of Radix Ginseng Rubra, 10 ~ 14 parts, Fructus Jujubae, 8 ~ 12 parts of Ramulus Cinnamomi, 8 ~ 12 parts, Rhizoma Zingiberis Recens, 10 ~ 14 parts of the Radix Paeoniae Albas, 4 ~ 8 parts of Radix Glycyrrhizae Preparatas.
Described best in quality proportioning is selected as 24 parts of Radix Bupleuri, 10 parts of Radix Scutellariaes, 12 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 6 parts, Natrii Sulfas, 10 parts of Radix Ginseng Rubra, 12 parts, Fructus Jujubae, 10 parts of Ramulus Cinnamomi, 10 parts, Rhizoma Zingiberis Recens, 12 parts of the Radix Paeoniae Albas, 6 parts of Radix Glycyrrhizae Preparatas.
Beneficial effect: the present invention with Radix Bupleuri add Natrii Sulfas rush down clearly hot and suffocating, regulating functional activities of qi, with Ramulus Cinnamomi harmonizing yingfen and weifen, pungent loose diathermanous; Not only therapeutic effect is good, and has no side effect.
The specific embodiment
Embodiment mono-: described quality proportioning is selected as 24 parts of Radix Bupleuri, 10 parts of Radix Scutellariaes, 12 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 6 parts, Natrii Sulfas, 10 parts of Radix Ginseng Rubra, 12 parts, Fructus Jujubae, 10 parts of Ramulus Cinnamomi, 10 parts, Rhizoma Zingiberis Recens, 12 parts of the Radix Paeoniae Albas, 6 parts of Radix Glycyrrhizae Preparatas.
Embodiment bis-: described quality proportioning is selected as 22 parts of Radix Bupleuri, 11 parts of Radix Scutellariaes, 12 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 7 parts, Natrii Sulfas, 9 parts of Radix Ginseng Rubra, 13 parts, Fructus Jujubae, 9 parts of Ramulus Cinnamomi, 10 parts, Rhizoma Zingiberis Recens, 13 parts of the Radix Paeoniae Albas, 6 parts of Radix Glycyrrhizae Preparatas.
Embodiment tri-: described quality proportioning is selected as 25 parts of Radix Bupleuri, 11 parts of Radix Scutellariaes, 10 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 6 parts, Natrii Sulfas, 11 parts of Radix Ginseng Rubra, 10 parts, Fructus Jujubae, 11 parts of Ramulus Cinnamomi, 8 parts, Rhizoma Zingiberis Recens, 13 parts of the Radix Paeoniae Albas, 7 parts of Radix Glycyrrhizae Preparatas.
Claims (2)
1. a formula for the treatment of immunologic hypofunction, is characterized in that: described quality proportioning is selected as 22 ~ 26 parts of Radix Bupleuri, 8 ~ 12 parts of Radix Scutellariaes, 10 ~ 14 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 4 ~ 8 parts, Natrii Sulfas, 8 ~ 12 parts of Radix Ginseng Rubra, 10 ~ 14 parts, Fructus Jujubae, 8 ~ 12 parts of Ramulus Cinnamomi, 8 ~ 12 parts, Rhizoma Zingiberis Recens, 10 ~ 14 parts of the Radix Paeoniae Albas, 4 ~ 8 parts of Radix Glycyrrhizae Preparatas.
2. a kind of formula for the treatment of immunologic hypofunction according to claim 1, is characterized in that: described best in quality proportioning is selected as 24 parts of Radix Bupleuri, 10 parts of Radix Scutellariaes, 12 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 6 parts, Natrii Sulfas, 10 parts of Radix Ginseng Rubra, 12 parts, Fructus Jujubae, 10 parts of Ramulus Cinnamomi, 10 parts, Rhizoma Zingiberis Recens, 12 parts of the Radix Paeoniae Albas, 6 parts of Radix Glycyrrhizae Preparatas.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410509478.7A CN104189879A (en) | 2014-09-29 | 2014-09-29 | Formula for treating immunocom promise |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410509478.7A CN104189879A (en) | 2014-09-29 | 2014-09-29 | Formula for treating immunocom promise |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104189879A true CN104189879A (en) | 2014-12-10 |
Family
ID=52075350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410509478.7A Withdrawn CN104189879A (en) | 2014-09-29 | 2014-09-29 | Formula for treating immunocom promise |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104189879A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11273191B2 (en) * | 2020-03-30 | 2022-03-15 | Script Essentials, Llc | Administering compositions for improved immune system functioning |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488874A (en) * | 2011-12-14 | 2012-06-13 | 哈药集团中药二厂 | Method for preparing bupleurum and cassia twig freeze-dried oral preparation |
| CN103721216A (en) * | 2012-10-15 | 2014-04-16 | 戴秀芳 | Chinese medicinal composition for treating coronary heart disease |
-
2014
- 2014-09-29 CN CN201410509478.7A patent/CN104189879A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488874A (en) * | 2011-12-14 | 2012-06-13 | 哈药集团中药二厂 | Method for preparing bupleurum and cassia twig freeze-dried oral preparation |
| CN103721216A (en) * | 2012-10-15 | 2014-04-16 | 戴秀芳 | Chinese medicinal composition for treating coronary heart disease |
Non-Patent Citations (1)
| Title |
|---|
| 张林海: "柴胡桂枝汤加味治顽疾四则", 《光明中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11273191B2 (en) * | 2020-03-30 | 2022-03-15 | Script Essentials, Llc | Administering compositions for improved immune system functioning |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755619B (en) | Traditional Chinese medicine health care product for treating chronic bronchitis | |
| CN103536884A (en) | Broad-spectrum epidemic preventing antiviral traditional Chinese medicine composition | |
| CN103446505B (en) | Traditional Chinese medicine composition for treating tuberculosis | |
| CN104189879A (en) | Formula for treating immunocom promise | |
| CN103316201B (en) | A kind of Chinese medicine composition for the treatment of pneumonia | |
| CN103893502A (en) | Traditional Chinese medicine for treating phlyctenular conjunctivitis | |
| CN102716258A (en) | Capsule for treating viral influenza | |
| CN102940725B (en) | Traditional Chinese medicine composition for treating viral cold | |
| CN103027956A (en) | Traditional Chinese medicine for treating virus-type influenza and preparation method thereof | |
| CN103933221A (en) | Medicament for preventing and treating influenza | |
| Kumari et al. | Pharmacological Approaches to Investigate the Potential Herbal Medicine (Decoction) in Treating COVID-19 | |
| CN102552404A (en) | Antipyretic | |
| CN105412494A (en) | Medicine for treating cold | |
| CN105477403A (en) | Traditional Chinese medicine formula for treating bronchiectasis caused by fire excess from yin deficiency and weakness | |
| CN105998673A (en) | Traditional Chinese medicine fumigation and washing agent for treating crusted tetter | |
| CN103550556B (en) | A kind of Chinese medicine composition preventing and treating influenza | |
| CN106511851A (en) | Traditional Chinese medicine compound for cold and productive cough | |
| CN106138864A (en) | A kind of combination of Chinese medicine treating pneumonia | |
| CN103599324B (en) | A kind of Chinese medicine for the treatment of joint injury | |
| CN104398905A (en) | Traditional Chinese medicine for treating viral influenza | |
| CN102727843B (en) | Traditional Chinese medicine for treating thrombocytopenia through invigorating spleen | |
| CN103394052A (en) | Traditional Chinese medicament for treating chronic colitis and preparation method thereof | |
| Hong et al. | Discussion on the Laws of Traditional Chinese Medical Treatment of H1N1 Influenza Based on a Cohort Study | |
| CN104225232A (en) | Traditional Chinese medicine composition for treating viral myocarditis | |
| CN101757090B (en) | Medicine composite for treating avian infectious bronchitis nephritis as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C04 | Withdrawal of patent application after publication (patent law 2001) | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20141210 |